Keyphrases
End-stage Renal Disease
92%
Chronic Kidney Disease
60%
Glomerular Filtration Rate
49%
Kidney Transplantation
49%
Type 2 Diabetic Patients
48%
Uremic Patients
47%
Renal Function
42%
Denmark
39%
Transplantation
39%
Glucagon
39%
Type I Diabetes
39%
Type 1 Diabetes Mellitus (T1DM)
39%
Lithium
37%
Estimated Glomerular Filtration Rate
37%
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
33%
Placebo
33%
Insulin Secretion
30%
Glucagon-like
28%
Egfr
27%
Non-diabetic
27%
Preeclampsia
26%
Pre-diabetes (pre-DM)
26%
Orosomucoid
25%
Type 2 Diabetes Mellitus (T2DM)
23%
Urinary Albumin Excretion
23%
Insulin Sensitivity
22%
Anticonvulsant
21%
Diabetic Nephropathy
20%
LDL Cholesterol
20%
National Cohort Study
20%
Rate Ratio
18%
Dialysis
18%
Ezetimibe
18%
Glucose-dependent Insulinotropic Polypeptide
17%
Creatinine
17%
Randomized Placebo-controlled Trial
16%
First Week
16%
Growth Hormone
16%
Rapid Decline
16%
Cimetidine
16%
Mannose-binding Lectin
16%
Liraglutide
16%
Renal Denervation
16%
Renal Protection
16%
Investigator-initiated
16%
Hemodialysis Patients
16%
Confidence Interval
16%
Plasma Concentration
15%
Simvastatin
15%
Pulse Wave Velocity
15%
Medicine and Dentistry
End Stage Renal Disease
100%
Diabetes Mellitus
78%
Kidney Transplantation
60%
Kidney Function
58%
Glomerular Filtration Rate
45%
Polycystic Kidney Disease
39%
Urinary System
32%
Chronic Kidney Disease
31%
Insulin Dependent Diabetes Mellitus
30%
Diabetes
30%
Impaired Glucose Tolerance
24%
Insulin Sensitivity
23%
Insulin Release
22%
Pulse Wave Velocity
21%
Glucagon Like Peptide 1
20%
Renal Replacement Therapy
20%
Patient with Type 2 Diabetes
18%
Nephropathy
18%
Pre-Eclampsia
18%
Orosomucoid
16%
Human immunodeficiency virus
16%
Mannose Binding Lectin
16%
Renal Protection
16%
Diabetic Nephropathy
16%
Glucagon
16%
Prevalence
15%
Incretin
15%
